Riskpilot← Back to searchSign inGet full accessLUNDEHAGEN AS
ASActiveOrg 926461192Ringsvegen 145, 2390 MoelvGeneral medical practice activities · NACE 8621Est. 20215 employees
Revenue 2024
NOK 6,1M
+11% vs 2023
EBITDA margin
17.6%
+889% vs 2023
Equity ratio
52.6%
Financial strength
Net profit 2024
NOK 561K
+430% vs 2023
| Revenue | NOK 6,1M | +11% |
| EBITDA | NOK 1,1M | +889% |
| Net profit | NOK 561K | +430% |
| Total assets | NOK 1,3M | -33% |
| Equity | NOK 674K | +493% |
| Employees | 5 | — |
Legal name
LUNDEHAGEN AS
Org number
926461192
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
26. januar 2021
Share capital
NOK 230 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg. Styrets leder alene. Daglig leder alene.
Company purpose
Legevirksomhet, psykoterapi, landbruksrelaterte tjenester knyttet til bruk av dyr i terapeutisk øyemed. Legevirksomhet dekker arbeid innen allmennmedisinsk og psykiatrisk fagområde.
Address
Ringsvegen 145, 2390 Moelv
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 4 111 | 3 786 | 5 524 | 6 113 |
| Staff expenses | −1 288 | −1 094 | −965 | −1 055 |
| EBITDA | 452 | −65 | 109 | 1 074 |
| Depreciation & amort. | −30 | −194 | −210 | −256 |
| EBIT | 422 | −259 | −101 | 818 |
| Net financials | −26 | −63 | −117 | −117 |
| Profit before tax | 396 | −323 | −218 | 701 |
| Tax | 85 | −71 | −48 | 140 |
| Net profit | 311 | −252 | −170 | 561 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 2 199 | 2 045 | 1 908 | 1 282 |
| Equity | 535 | 284 | 114 | 674 |
| Long-term debt | 1 185 | 1 040 | 927 | 838 |
| Short-term debt | 479 | 721 | 867 | −231 |
| Total debt | 1 664 | 1 761 | 1 794 | 607 |
EBITDA margin
17.6%
This company
15.8%
Market median
+11% vs market
20212024
Equity ratio
52.6%
This company
38.2%
Market median
+38% vs market
20212024
Return on equity
83.1%
This company
18.4%
Market median
+352% vs market
20212024
Net profit margin
9.2%
This company
8.1%
Market median
+14% vs market
20212024
Asset turnover
4.77×
This company
1.12×
Market median
+326% vs market
20212024
Debt / equity
0.90×
This company
0.62×
Market median
+45% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
OK Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50% | 50% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LUNDEHAGEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ole Kaare Lunde | Chief Executive Officer | 0 companies |
| Norunn Helena Lauvland Kogstad | Chairman | 0 companies |